Uterine Papillary Serous Carcinoma (UPSC): A Rare Case Report
DOI:
https://doi.org/10.21649/akemu.v32i1.5993Keywords:
Uterine Papillary Serous Carcinoma (UPSC), Rare Cancer Case, Endometrial Carcinoma, Uterine Cancer, Serous CarcinomaAbstract
Uterine papillary serous carcinoma (UPSC) accounts for 5-10% endometrial cancers, although they account for majority of endometrial cancer mortality. This case report discusses a 58-year-old female menopausal for fifteen years presented with vaginal discharge for two months, post-menopausal bleeding for 20 days, and lower abdominal pain after 20 days. Bloating, vomiting, constipation, increased urine frequency, and abnormal uterine bleeding were eventually diagnosed as Uterine Papillary Serous Carcinoma (UPSC).The case emphasizes the limitations of early identification, the significance of histological confirmation, and the therapeutic choices for controlling this aggressive tumor.
References
1. Liu KT, Chang YC, Lin YC, Chang JL. An unusual uterine papillary serous carcinoma with post therapy disseminating metastasis presenting as primary renal malignancy: a case report. Ann med surg 2024; 86(1):456-62. https://doi.org/10.1097/MS9.0000000000001574
2. You X, Dong Y, Wang J, Cheng Y, Jia Y, Zhang X, et al. The comparison of pure uterine serous carcinoma and mixed tumor with serous component: a single-institution review of 91 cases. BMC cancer. 2024; 24(1):99. https://doi.org/10.1186/s12885-023-11793-3
3. How JA, Jazaeri AA, Westin SN, Lawson BC, Klopp AH, Soliman PT, et al. Translating biological insights into improved management of endometrial cancer. Nat. Rev. Clin Oncol. 2024; 21(11):781-800. https://doi.org/10.1038/s41571-024-00934-7
4. Arend RC, Goel N, Roane BM, Foxall ME, Dholakia J, Londoño AI, et al. Systematic Next Generation Sequencing is feasible in clinical practice and identifies opportunities for targeted therapy in women with uterine cancer: Results from a prospective cohort study. Gynecol Oncol 2021;163(1):85-92. https://doi.org/10.1016/j.ygyno.2021.07.017
5. Yuce Sari S, Guler OC, Oymak E, Gultekin M, Yigit E, Kahvecioglu A, et al. Uterine papillary serous and clear cell carcinomas: Comparison of characteristics and clinical outcomes. J Obstet Gynaecol Res. 2022;48(7):1876-87. https://doi.org/10.1111/jog.15247Digital Object Identifier (DOI)
6. Agarwal A, Yadav S, Dusane R, Menon S, Rekhi B, Deodhar KK. Endometrial serous carcinoma: A retrospective review of histological features & their clinicopathological association with disease-free survival & overall survival. Indian J Med Res. 2022;156(1):83-93. https://doi.org/10.4103/ijmr.IJMR_697_20
7. Hui P. Endometrial polyp in postmenopausal women: an epicenter for the development of endometrial serous carcinoma Arch Pathol Lab Med. 2023 ;147(4):413-7. https://doi.org/10.5858/arpa.2021-0557-RA
8. Crudele L, Piccinin E, Moschetta A. Visceral adiposity and cancer: role in pathogenesis and prognosis. Nutrients. 2021;13(6):2101. https://doi.org/10.3390/nu13062101
9. Cusimano MC, Chiu M, Ferguson SE, Moineddin R, Aktar S, Liu N, et al. Association of bilateral salpingo-oophorectomy with all cause and cause specific mortality: population based cohort study. Bmj. 2021 ;375. https://doi.org/10.1136/bmj-2021-067528
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Annals of King Edward Medical University
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments publications@kemu.edu.pk
